1globe Health Institute LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2012-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.1globe-usa.com
Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (33.3%)phase_2_3
1 (33.3%)Phase 3
1 (33.3%)A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Metastatic Pancreatic Cancer
- Interventions
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- 1Globe Health Institute LLC
- Target Recruit Count
- 336
- Registration Number
- NCT03721744
- Locations
- 🇨🇳
Anhui Provincial Cancer Hospital, Hefei, Anhui, China
🇨🇳The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Beijng Cancer Hospital, Beijing, Beijing, China
A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer
Phase 3
- Conditions
- Previously Treated Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2019-06-18
- Lead Sponsor
- 1Globe Health Institute LLC
- Target Recruit Count
- 668
- Registration Number
- NCT03522649
- Locations
- 🇨🇳
First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
🇨🇳The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
News
No news found